Patent Assignment
Reel/Frame 065271/0025
Security Interest
Recorded: 2023-10-18
Pages: 20
Assignors
CYDEX PHARMACEUTICALS, INC.
Executed: 2023-10-12
LIGAND PHARMACEUTICALS INCORPORATED
Executed: 2023-10-12
METABASIS THERAPEUTICS, INC.
Executed: 2023-10-12
PFENEX INC.
Executed: 2023-10-12
Assignee
CITIBANK, N.A., AS ADMINISTRATIVE AGENT
6400 LAS COLINAS BLVD., MAIL STOP CC1-30, IRVING, TEXAS, 75039
Covered Properties
(153)
Novel Bisamidate Phosphonate Prodrugs
Novel Aryl Fructose-1,6-Bisphosphatase Inhibitors
Tricyclic Quinolinone and Tricyclic Quinoline Androgen Receptor Modulator Compounds and Methods
Tricyclic Androgen Receptor Modulator Compounds and Methods
Novel Phosphorus-Containing Thyromimetics
Androgen Receptor Modulator Compounds and Methods
5-(1',1'-Cycloalkyl/Alkenyl)Methylidene 1,2-Dihydro-5H-Chromeno[3,4-F]Quinolines as Selective Progesterone Receptor Modulator Compounds
5-Cycloalkenyl 5H-Chromeno[3,4-F]Quinoline Derivatives as Selective Progesterone Receptor Modulator Compounds
Novel Cyclic Phosphate Diesters of 1,3-Propane-1-Aryl Diols and Their Use in Preparing Prodrugs
Novel Cytarabine Monophosphate Prodrugs
Prodrugs for Liver Specific Drug Delivery
Capsules Containing Aqueous Fill Compositions Stabilized with Derivatized Cyclodextrin
Lewis Acid Mediated Synthesis of Cyclic Esters
Thrombopoietin Activity Modulating Compounds and Methods
Novel Cyclic Phosphate Diesters of 1,3-Propane-1-Aryl Diols and Their Use in Preparing Prodrugs
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Novel Cytarabine Monophosphate Prodrugs
Novel 2'-C-Methyl Nucleoside Derivatives
Androgen Receptor Modulator Compounds
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Nucleoside Prodrugs and Uses Thereof
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Sulfoalkyl Ether Cyclodextrin Compositions
Compounds and Processes for Preparing Substituted Aminomethyl-2,3,8,9-Tetrahydro-7H-1,4-Dioxino[2,3-E]Indol-8-Ones
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Sulfoalkyl Ether Cyclodextrin Compositions
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
Novel Phosphorus-Containing Prodrugs
Thyromimetics for the Treatment of Fatty Liver Diseases
Glucagon Antagonists
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Methods of Decreasing Sebum Production in the Skin
DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
Hematopoietic Growth Factor Mimetic Small Molecule Compounds and Their Uses
Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Biaryl Oxyacetic Acid Compounds
Sulfoalkyl Ether Cyclodextrin Compositions
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Androgen Receptor Modulator Compounds and Methods
Nitric Oxide-Releasing Nanorods and Their Methods of Use
Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Heterocycle Amines and Uses Thereof
Novel Antagonists of the Glucagon Receptor
Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Methods and Compositions Associated with the Granulocyte Colony-Stimulating Factor Receptor
Manufacturing Process for Cyclodextrin Derivatives
Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Novel Nucleotide Prodrug Compounds and Use
Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Androgen Receptor Modulator Compounds and Methods
Glucagon Antagonists
Novel Activators of Glucokinase
Inhibitors of Diacylglycerol O-Acyltransferase 1 (Dgat-1) and Uses Thereof
Method for Treating Glomerulosclerosis
Hematopoietic Growth Factor Mimetic Small Molecule Compounds and Their Uses
Methods of Treatment Associated with the Granulocyte Colony-Stimulating Factor Receptor
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Topical Compositions and Methods of Using the Same
Sulfoalkyl Ether Cyclodextrin Compositions
Heterocycle Amines and Uses Thereof
Derivatives of Uridine 5'-Cyclophosphate Useful to Treat Hepatitis C Viral Infections
Imidazo-Fused Heterocycles and Uses Thereof
Methods and Compositions for Modulating Hormone Levels
Prodrug Compounds and Their Uses
Inhibitors of Diacylglycerol O-Acyltransferase 1 (Dgat-1) and Uses Thereof
Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
Sulfoalkyl Ether Cyclodextrin Compositions
Methods and Compositions Associated with the Granulocyte Colony-Stimulating Factor Receptor
Prodrug Compounds and Uses Therof
Topical Antiviral Compositions and Methods of Using the Same
Nitric Oxide Releasing Nail Coating Compositions, Nitric Oxide Releasing Nail Coatings, and Methods of Using the Same
Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Fractionated Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Compositions Containing Silymarin and Sulfoalkyl Ether Cyclodextrin and Methods of Using the Same
Derivatives of Uridine 5'-Cyclophosphate Useful to Treat Hepatitis C Viral Infections
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Method for Treating Disorders Associated with Glomerular Function
Manufacturing Process for Cyclodextrin Derivatives
Glucagon Antagonists
Combinations and Methods for the Treatment and/or Prevention of Fungal Infections
Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Methods of Treatment Associated with the Granulocyte Colony-Stimulating Factor Receptor
Prodrug Compounds and Uses Therof
Heterocycle Amines and Uses Thereof
Inhibitors of Diacylglycerol O-Acyltransferase 1 (Dgat-1) and Uses Thereof
Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Thyroid Hormone Receptor Agonist and Use Thereof
Compositions for Treating Inflammation and Methods of Treating the Same
Compositions, Systems, Kits, and Methods for Treating an Infection
Use of Thyroid Beta-Agonists
Methods and Compositions Associated with the Granulocyte Colony-Stimulating Factor Receptor
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Method for Production of Recombinant Erwinia Asparaginase
Sulfoalkyl Ether Cyclodextrin Compositions
Thyromimetics for the Treatment of Fatty Liver Diseases
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
Glucagon Antagonists
Method of Reducing Thyroid-Associated Side Effects
Application:
16/333,513 →
Publication:
US 2019/0255080
Formulations Containing Acetaminophen and Sulfoalkyl Ether Cyclodextrin
Novel Antagonists of the Glucagon Receptor
Compounds, Compositions and Methods for Inhibiting a Pathogen and/or Modifying Mucus
Prodrug Compounds and Their Uses
Methods and Compositions for Modulating Hormone Levels
Topical Compositions and Methods of Using the Same
Topical Compositions and Methods of Using the Same
Application:
16/623,834 →
Publication:
US 2020/0188261
Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost
Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Heterocycle Amines and Uses Thereof
Manufacturing Process for Cyclodextrin Derivatives
Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
Compositions Containing Silymarin and Sulfoalkyl Ether Cyclodextrin and Methods of Using the Same
Methods and Compositions Associated with the Granulocyte Colony-Stimulating Factor Receptor
Acetal Compounds and Therapeutic Uses Thereof
Glucagon Receptor Antagonists
Nitric Oxide Releasing Suppositories and Methods of Use Thereof
Selective Androgen Receptor Modulators (Sarms) and Uses Thereof
Method for Production of Recombinant Erwinia Asparaginase
Sulfoalkyl Ether Cyclodextrin Compositions
Imidazo-Fused Heterocycles and Uses Thereof
Fractionated Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Application:
17/194,980 →
Publication:
US 2021/0379000
Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
Extended Nitric Oxide-Releasing Polymers via Functionalized Mesoporous Silica Nanoparticles
Heterocycle Amines and Uses Thereof
Manufacturing Process for Cyclodextrin Derivatives
Application:
17/555,286 →
Publication:
US 2022/0332853
Cyclic Phosphate Compounds
Application:
17/604,681 →
Publication:
US 2022/0220145
Crystalline Forms and Methods of Producing Crystalline Forms of a Compound
Use of Thyroid Beta-Agonists
Alkylated Cyclodextrin Compositions and Processes for Preparing and Using the Same
Application:
17/776,199 →
Publication:
US 2023/0002513
Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost
Application:
17/818,653 →
Publication:
US 2022/0387444
Nucleotide Prodrug Compounds
Composition Containing Cyclodextrin and Busulfan
Application:
17/949,970 →
Publication:
US 2023/0255919
Benzyloxy Phosph(on)Ate Compounds
Nitric Oxide-Releasing Topical Ointments and Dry Powder Dressings, Methods of Using the Same and Methods of Forming the Same
Application:
61/235,933 →